Affimed N.V. (AFMDQ) Stock Competitors & Peer Comparison
See (AFMDQ) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AFMDQ | $0.00 | +0.00% | 1.6K | N/A | -$5.24 | N/A |
| NONOF | $44.00 | +4.74% | 197.1B | 10.42 | $4.26 | +4.07% |
| CSLLY | $19.06 | -0.73% | 73.9B | 12.40 | $1.54 | +3.79% |
| UCBJF | $321.05 | +3.56% | 61.1B | 34.67 | $9.26 | +0.53% |
| UCBJY | $158.72 | +0.54% | 60.3B | 34.23 | $4.63 | +0.54% |
| ARGNF | $900.00 | +1.69% | 55.7B | 40.04 | $22.48 | N/A |
| CMXHF | $74.14 | -0.04% | 35.5B | 12.02 | $6.17 | +3.94% |
| WXIBF | $4.40 | +0.00% | 18.2B | 25.88 | $0.17 | N/A |
| IVBXF | $9.79 | -9.01% | 17B | 139.86 | $0.07 | N/A |
| WXXWY | $7.89 | +4.46% | 16.3B | 23.34 | $0.34 | N/A |
Stock Comparison
AFMDQ vs NONOF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, NONOF has a market cap of 197.1B. Regarding current trading prices, AFMDQ is priced at $0.00, while NONOF trades at $44.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas NONOF's P/E ratio is 10.42. In terms of profitability, AFMDQ's ROE is -1.01%, compared to NONOF's ROE of +0.66%. Regarding short-term risk, AFMDQ and NONOF have similar daily volatility (0.00).Check NONOF's competition here
AFMDQ vs CSLLY Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, CSLLY has a market cap of 73.9B. Regarding current trading prices, AFMDQ is priced at $0.00, while CSLLY trades at $19.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas CSLLY's P/E ratio is 12.40. In terms of profitability, AFMDQ's ROE is -1.01%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, AFMDQ is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check CSLLY's competition here
AFMDQ vs UCBJF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, UCBJF has a market cap of 61.1B. Regarding current trading prices, AFMDQ is priced at $0.00, while UCBJF trades at $321.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas UCBJF's P/E ratio is 34.67. In terms of profitability, AFMDQ's ROE is -1.01%, compared to UCBJF's ROE of +0.15%. Regarding short-term risk, AFMDQ and UCBJF have similar daily volatility (0.00).Check UCBJF's competition here
AFMDQ vs UCBJY Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, UCBJY has a market cap of 60.3B. Regarding current trading prices, AFMDQ is priced at $0.00, while UCBJY trades at $158.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas UCBJY's P/E ratio is 34.23. In terms of profitability, AFMDQ's ROE is -1.01%, compared to UCBJY's ROE of +0.15%. Regarding short-term risk, AFMDQ is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check UCBJY's competition here
AFMDQ vs ARGNF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, ARGNF has a market cap of 55.7B. Regarding current trading prices, AFMDQ is priced at $0.00, while ARGNF trades at $900.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ARGNF's P/E ratio is 40.04. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ARGNF's ROE of +0.23%. Regarding short-term risk, AFMDQ and ARGNF have similar daily volatility (0.00).Check ARGNF's competition here
AFMDQ vs CMXHF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, CMXHF has a market cap of 35.5B. Regarding current trading prices, AFMDQ is priced at $0.00, while CMXHF trades at $74.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas CMXHF's P/E ratio is 12.02. In terms of profitability, AFMDQ's ROE is -1.01%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, AFMDQ and CMXHF have similar daily volatility (0.00).Check CMXHF's competition here
AFMDQ vs WXIBF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, WXIBF has a market cap of 18.2B. Regarding current trading prices, AFMDQ is priced at $0.00, while WXIBF trades at $4.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas WXIBF's P/E ratio is 25.88. In terms of profitability, AFMDQ's ROE is -1.01%, compared to WXIBF's ROE of +0.11%. Regarding short-term risk, AFMDQ and WXIBF have similar daily volatility (0.00).Check WXIBF's competition here
AFMDQ vs IVBXF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, IVBXF has a market cap of 17B. Regarding current trading prices, AFMDQ is priced at $0.00, while IVBXF trades at $9.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas IVBXF's P/E ratio is 139.86. In terms of profitability, AFMDQ's ROE is -1.01%, compared to IVBXF's ROE of +0.05%. Regarding short-term risk, AFMDQ is less volatile compared to IVBXF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check IVBXF's competition here
AFMDQ vs WXXWY Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, WXXWY has a market cap of 16.3B. Regarding current trading prices, AFMDQ is priced at $0.00, while WXXWY trades at $7.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas WXXWY's P/E ratio is 23.34. In terms of profitability, AFMDQ's ROE is -1.01%, compared to WXXWY's ROE of +0.11%. Regarding short-term risk, AFMDQ is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check WXXWY's competition here
AFMDQ vs GNMSF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, GNMSF has a market cap of 15.3B. Regarding current trading prices, AFMDQ is priced at $0.00, while GNMSF trades at $249.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas GNMSF's P/E ratio is 18.94. In terms of profitability, AFMDQ's ROE is -1.01%, compared to GNMSF's ROE of +0.15%. Regarding short-term risk, AFMDQ is less volatile compared to GNMSF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check GNMSF's competition here
AFMDQ vs SBMFF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, SBMFF has a market cap of 11.3B. Regarding current trading prices, AFMDQ is priced at $0.00, while SBMFF trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas SBMFF's P/E ratio is 21.10. In terms of profitability, AFMDQ's ROE is -1.01%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, AFMDQ and SBMFF have similar daily volatility (0.00).Check SBMFF's competition here
AFMDQ vs SBHMY Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, SBHMY has a market cap of 10.1B. Regarding current trading prices, AFMDQ is priced at $0.00, while SBHMY trades at $11.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas SBHMY's P/E ratio is 29.66. In terms of profitability, AFMDQ's ROE is -1.01%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, AFMDQ and SBHMY have similar daily volatility (0.00).Check SBHMY's competition here
AFMDQ vs BRRGF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, AFMDQ is priced at $0.00, while BRRGF trades at $97.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, AFMDQ's ROE is -1.01%, compared to BRRGF's ROE of -0.97%. Regarding short-term risk, AFMDQ is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check BRRGF's competition here
AFMDQ vs AAVXF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, AAVXF has a market cap of 8.1B. Regarding current trading prices, AFMDQ is priced at $0.00, while AAVXF trades at $101.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas AAVXF's P/E ratio is -19.03. In terms of profitability, AFMDQ's ROE is -1.01%, compared to AAVXF's ROE of -1.65%. Regarding short-term risk, AFMDQ and AAVXF have similar daily volatility (0.00).Check AAVXF's competition here
AFMDQ vs ODTC Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, AFMDQ is priced at $0.00, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ODTC's P/E ratio is 1.07. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, AFMDQ and ODTC have similar daily volatility (0.00).Check ODTC's competition here
AFMDQ vs AKBLF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, AKBLF has a market cap of 7.8B. Regarding current trading prices, AFMDQ is priced at $0.00, while AKBLF trades at $38.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas AKBLF's P/E ratio is 43.21. In terms of profitability, AFMDQ's ROE is -1.01%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, AFMDQ is less volatile compared to AKBLF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check AKBLF's competition here
AFMDQ vs REGMF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, REGMF has a market cap of 6.8B. Regarding current trading prices, AFMDQ is priced at $0.00, while REGMF trades at $12.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas REGMF's P/E ratio is 63.42. In terms of profitability, AFMDQ's ROE is -1.01%, compared to REGMF's ROE of +0.42%. Regarding short-term risk, AFMDQ is less volatile compared to REGMF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check REGMF's competition here
AFMDQ vs TRSBF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, TRSBF has a market cap of 5.5B. Regarding current trading prices, AFMDQ is priced at $0.00, while TRSBF trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas TRSBF's P/E ratio is 4.31. In terms of profitability, AFMDQ's ROE is -1.01%, compared to TRSBF's ROE of +0.38%. Regarding short-term risk, AFMDQ and TRSBF have similar daily volatility (0.00).Check TRSBF's competition here
AFMDQ vs ABCZF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, AFMDQ is priced at $0.00, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ABCZF's ROE of +0.22%. Regarding short-term risk, AFMDQ and ABCZF have similar daily volatility (0.00).Check ABCZF's competition here
AFMDQ vs SHJBF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, SHJBF has a market cap of 4.8B. Regarding current trading prices, AFMDQ is priced at $0.00, while SHJBF trades at $3.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas SHJBF's P/E ratio is -27.92. In terms of profitability, AFMDQ's ROE is -1.01%, compared to SHJBF's ROE of -0.11%. Regarding short-term risk, AFMDQ is less volatile compared to SHJBF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check SHJBF's competition here
AFMDQ vs GNNSF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, GNNSF has a market cap of 3.5B. Regarding current trading prices, AFMDQ is priced at $0.00, while GNNSF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas GNNSF's P/E ratio is -6.40. In terms of profitability, AFMDQ's ROE is -1.01%, compared to GNNSF's ROE of -0.13%. Regarding short-term risk, AFMDQ is less volatile compared to GNNSF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check GNNSF's competition here
AFMDQ vs TLPPF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, TLPPF has a market cap of 3.2B. Regarding current trading prices, AFMDQ is priced at $0.00, while TLPPF trades at $9.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas TLPPF's P/E ratio is -476.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, AFMDQ and TLPPF have similar daily volatility (0.00).Check TLPPF's competition here
AFMDQ vs ZLDPF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, ZLDPF has a market cap of 3.2B. Regarding current trading prices, AFMDQ is priced at $0.00, while ZLDPF trades at $44.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ZLDPF's P/E ratio is 3.22. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ZLDPF's ROE of +0.43%. Regarding short-term risk, AFMDQ and ZLDPF have similar daily volatility (0.00).Check ZLDPF's competition here
AFMDQ vs BRCTF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, BRCTF has a market cap of 3.1B. Regarding current trading prices, AFMDQ is priced at $0.00, while BRCTF trades at $35.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas BRCTF's P/E ratio is 140.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to BRCTF's ROE of +0.10%. Regarding short-term risk, AFMDQ and BRCTF have similar daily volatility (0.00).Check BRCTF's competition here
AFMDQ vs MPSYF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, AFMDQ is priced at $0.00, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, AFMDQ's ROE is -1.01%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, AFMDQ is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check MPSYF's competition here
AFMDQ vs INCPF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, INCPF has a market cap of 2.3B. Regarding current trading prices, AFMDQ is priced at $0.00, while INCPF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas INCPF's P/E ratio is 25.83. In terms of profitability, AFMDQ's ROE is -1.01%, compared to INCPF's ROE of +0.10%. Regarding short-term risk, AFMDQ is less volatile compared to INCPF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check INCPF's competition here
AFMDQ vs BVNRY Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, BVNRY has a market cap of 2.2B. Regarding current trading prices, AFMDQ is priced at $0.00, while BVNRY trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas BVNRY's P/E ratio is 12.11. In terms of profitability, AFMDQ's ROE is -1.01%, compared to BVNRY's ROE of +0.09%. Regarding short-term risk, AFMDQ is less volatile compared to BVNRY. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check BVNRY's competition here
AFMDQ vs BVNKF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, BVNKF has a market cap of 2.1B. Regarding current trading prices, AFMDQ is priced at $0.00, while BVNKF trades at $27.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas BVNKF's P/E ratio is 11.84. In terms of profitability, AFMDQ's ROE is -1.01%, compared to BVNKF's ROE of +0.09%. Regarding short-term risk, AFMDQ is less volatile compared to BVNKF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check BVNKF's competition here
AFMDQ vs GENSF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, GENSF has a market cap of 2.1B. Regarding current trading prices, AFMDQ is priced at $0.00, while GENSF trades at $31.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas GENSF's P/E ratio is 32.70. In terms of profitability, AFMDQ's ROE is -1.01%, compared to GENSF's ROE of +0.10%. Regarding short-term risk, AFMDQ is less volatile compared to GENSF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check GENSF's competition here
AFMDQ vs MEOBF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, MEOBF has a market cap of 2B. Regarding current trading prices, AFMDQ is priced at $0.00, while MEOBF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas MEOBF's P/E ratio is -22.14. In terms of profitability, AFMDQ's ROE is -1.01%, compared to MEOBF's ROE of -0.14%. Regarding short-term risk, AFMDQ is less volatile compared to MEOBF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check MEOBF's competition here
AFMDQ vs GLPGF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, GLPGF has a market cap of 1.9B. Regarding current trading prices, AFMDQ is priced at $0.00, while GLPGF trades at $28.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas GLPGF's P/E ratio is -3.50. In terms of profitability, AFMDQ's ROE is -1.01%, compared to GLPGF's ROE of +0.16%. Regarding short-term risk, AFMDQ and GLPGF have similar daily volatility (0.00).Check GLPGF's competition here
AFMDQ vs ASPHF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, ASPHF has a market cap of 1.7B. Regarding current trading prices, AFMDQ is priced at $0.00, while ASPHF trades at $4.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ASPHF's P/E ratio is -8.71. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ASPHF's ROE of -0.73%. Regarding short-term risk, AFMDQ and ASPHF have similar daily volatility (0.00).Check ASPHF's competition here
AFMDQ vs BIESF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, AFMDQ is priced at $0.00, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas BIESF's P/E ratio is -44.44. In terms of profitability, AFMDQ's ROE is -1.01%, compared to BIESF's ROE of -0.05%. Regarding short-term risk, AFMDQ and BIESF have similar daily volatility (0.00).Check BIESF's competition here
AFMDQ vs ONTTF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, ONTTF has a market cap of 1.6B. Regarding current trading prices, AFMDQ is priced at $0.00, while ONTTF trades at $1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ONTTF's P/E ratio is -8.04. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ONTTF's ROE of -0.29%. Regarding short-term risk, AFMDQ is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check ONTTF's competition here
AFMDQ vs IDRSF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, IDRSF has a market cap of 1.5B. Regarding current trading prices, AFMDQ is priced at $0.00, while IDRSF trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas IDRSF's P/E ratio is -4.46. In terms of profitability, AFMDQ's ROE is -1.01%, compared to IDRSF's ROE of +0.19%. Regarding short-term risk, AFMDQ is less volatile compared to IDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check IDRSF's competition here
AFMDQ vs ASCLF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, ASCLF has a market cap of 1.4B. Regarding current trading prices, AFMDQ is priced at $0.00, while ASCLF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ASCLF's P/E ratio is -27.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ASCLF's ROE of -0.19%. Regarding short-term risk, AFMDQ and ASCLF have similar daily volatility (0.00).Check ASCLF's competition here
AFMDQ vs PHMMF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, PHMMF has a market cap of 1.4B. Regarding current trading prices, AFMDQ is priced at $0.00, while PHMMF trades at $79.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas PHMMF's P/E ratio is 14.97. In terms of profitability, AFMDQ's ROE is -1.01%, compared to PHMMF's ROE of +0.36%. Regarding short-term risk, AFMDQ is less volatile compared to PHMMF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check PHMMF's competition here
AFMDQ vs HBMHF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, HBMHF has a market cap of 1.3B. Regarding current trading prices, AFMDQ is priced at $0.00, while HBMHF trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas HBMHF's P/E ratio is 13.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to HBMHF's ROE of +0.28%. Regarding short-term risk, AFMDQ is less volatile compared to HBMHF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check HBMHF's competition here
AFMDQ vs SNBIF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, AFMDQ is priced at $0.00, while SNBIF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, AFMDQ's ROE is -1.01%, compared to SNBIF's ROE of -0.89%. Regarding short-term risk, AFMDQ is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check SNBIF's competition here
AFMDQ vs MDCLF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, AFMDQ is priced at $0.00, while MDCLF trades at $34.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, AFMDQ's ROE is -1.01%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, AFMDQ and MDCLF have similar daily volatility (0.00).Check MDCLF's competition here
AFMDQ vs NURPF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, NURPF has a market cap of 1.1B. Regarding current trading prices, AFMDQ is priced at $0.00, while NURPF trades at $8.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas NURPF's P/E ratio is 55.47. In terms of profitability, AFMDQ's ROE is -1.01%, compared to NURPF's ROE of +0.09%. Regarding short-term risk, AFMDQ is less volatile compared to NURPF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check NURPF's competition here
AFMDQ vs CSBTF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, CSBTF has a market cap of 1B. Regarding current trading prices, AFMDQ is priced at $0.00, while CSBTF trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas CSBTF's P/E ratio is 325.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to CSBTF's ROE of +0.02%. Regarding short-term risk, AFMDQ and CSBTF have similar daily volatility (0.00).Check CSBTF's competition here
AFMDQ vs CSPHF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, CSPHF has a market cap of 950.1M. Regarding current trading prices, AFMDQ is priced at $0.00, while CSPHF trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas CSPHF's P/E ratio is -11.89. In terms of profitability, AFMDQ's ROE is -1.01%, compared to CSPHF's ROE of -0.64%. Regarding short-term risk, AFMDQ and CSPHF have similar daily volatility (0.00).Check CSPHF's competition here
AFMDQ vs BTTAY Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, AFMDQ is priced at $0.00, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, AFMDQ's ROE is -1.01%, compared to BTTAY's ROE of -0.05%. Regarding short-term risk, AFMDQ is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check BTTAY's competition here
AFMDQ vs TKBIF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, AFMDQ is priced at $0.00, while TKBIF trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas TKBIF's P/E ratio is -14.60. In terms of profitability, AFMDQ's ROE is -1.01%, compared to TKBIF's ROE of N/A. Regarding short-term risk, AFMDQ is less volatile compared to TKBIF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check TKBIF's competition here
AFMDQ vs PHGUF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, PHGUF has a market cap of 812.2M. Regarding current trading prices, AFMDQ is priced at $0.00, while PHGUF trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas PHGUF's P/E ratio is 57.50. In terms of profitability, AFMDQ's ROE is -1.01%, compared to PHGUF's ROE of +0.05%. Regarding short-term risk, AFMDQ is less volatile compared to PHGUF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check PHGUF's competition here
AFMDQ vs PPTDF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, PPTDF has a market cap of 771M. Regarding current trading prices, AFMDQ is priced at $0.00, while PPTDF trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas PPTDF's P/E ratio is -33.33. In terms of profitability, AFMDQ's ROE is -1.01%, compared to PPTDF's ROE of -0.05%. Regarding short-term risk, AFMDQ is less volatile compared to PPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check PPTDF's competition here
AFMDQ vs BPMUF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, BPMUF has a market cap of 746M. Regarding current trading prices, AFMDQ is priced at $0.00, while BPMUF trades at $60.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas BPMUF's P/E ratio is 8.47. In terms of profitability, AFMDQ's ROE is -1.01%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, AFMDQ and BPMUF have similar daily volatility (0.00).Check BPMUF's competition here
AFMDQ vs IVEVF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, IVEVF has a market cap of 741.2M. Regarding current trading prices, AFMDQ is priced at $0.00, while IVEVF trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas IVEVF's P/E ratio is -2.43. In terms of profitability, AFMDQ's ROE is -1.01%, compared to IVEVF's ROE of +18.92%. Regarding short-term risk, AFMDQ is less volatile compared to IVEVF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check IVEVF's competition here
AFMDQ vs SOLTF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, SOLTF has a market cap of 567.4M. Regarding current trading prices, AFMDQ is priced at $0.00, while SOLTF trades at $6.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas SOLTF's P/E ratio is -7.11. In terms of profitability, AFMDQ's ROE is -1.01%, compared to SOLTF's ROE of -0.16%. Regarding short-term risk, AFMDQ is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check SOLTF's competition here
AFMDQ vs GNFTF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, GNFTF has a market cap of 499.8M. Regarding current trading prices, AFMDQ is priced at $0.00, while GNFTF trades at $9.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas GNFTF's P/E ratio is -5.04. In terms of profitability, AFMDQ's ROE is -1.01%, compared to GNFTF's ROE of -5.96%. Regarding short-term risk, AFMDQ and GNFTF have similar daily volatility (0.00).Check GNFTF's competition here
AFMDQ vs INRLF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, INRLF has a market cap of 489.3M. Regarding current trading prices, AFMDQ is priced at $0.00, while INRLF trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas INRLF's P/E ratio is -2.80. In terms of profitability, AFMDQ's ROE is -1.01%, compared to INRLF's ROE of -1.06%. Regarding short-term risk, AFMDQ and INRLF have similar daily volatility (0.00).Check INRLF's competition here
AFMDQ vs AVCTF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, AVCTF has a market cap of 455M. Regarding current trading prices, AFMDQ is priced at $0.00, while AVCTF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas AVCTF's P/E ratio is -8.33. In terms of profitability, AFMDQ's ROE is -1.01%, compared to AVCTF's ROE of -29.83%. Regarding short-term risk, AFMDQ and AVCTF have similar daily volatility (0.00).Check AVCTF's competition here
AFMDQ vs RAONF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, AFMDQ is priced at $0.00, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas RAONF's P/E ratio is -43.33. In terms of profitability, AFMDQ's ROE is -1.01%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, AFMDQ is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check RAONF's competition here
AFMDQ vs GNFTY Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, AFMDQ is priced at $0.00, while GNFTY trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas GNFTY's P/E ratio is -9.94. In terms of profitability, AFMDQ's ROE is -1.01%, compared to GNFTY's ROE of -0.65%. Regarding short-term risk, AFMDQ is less volatile compared to GNFTY. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check GNFTY's competition here
AFMDQ vs TBGNF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, AFMDQ is priced at $0.00, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, AFMDQ's ROE is -1.01%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, AFMDQ and TBGNF have similar daily volatility (0.00).Check TBGNF's competition here
AFMDQ vs NWPHF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, NWPHF has a market cap of 416.1M. Regarding current trading prices, AFMDQ is priced at $0.00, while NWPHF trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas NWPHF's P/E ratio is -26.32. In terms of profitability, AFMDQ's ROE is -1.01%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, AFMDQ is less volatile compared to NWPHF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check NWPHF's competition here
AFMDQ vs PTCHF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, PTCHF has a market cap of 413.8M. Regarding current trading prices, AFMDQ is priced at $0.00, while PTCHF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas PTCHF's P/E ratio is -3.70. In terms of profitability, AFMDQ's ROE is -1.01%, compared to PTCHF's ROE of -0.32%. Regarding short-term risk, AFMDQ is less volatile compared to PTCHF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check PTCHF's competition here
AFMDQ vs CYDY Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, CYDY has a market cap of 390M. Regarding current trading prices, AFMDQ is priced at $0.00, while CYDY trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas CYDY's P/E ratio is -7.12. In terms of profitability, AFMDQ's ROE is -1.01%, compared to CYDY's ROE of +0.37%. Regarding short-term risk, AFMDQ is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check CYDY's competition here
AFMDQ vs VBIZF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, VBIZF has a market cap of 344.3M. Regarding current trading prices, AFMDQ is priced at $0.00, while VBIZF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas VBIZF's P/E ratio is 16.31. In terms of profitability, AFMDQ's ROE is -1.01%, compared to VBIZF's ROE of +0.06%. Regarding short-term risk, AFMDQ is less volatile compared to VBIZF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check VBIZF's competition here
AFMDQ vs SPHDF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, SPHDF has a market cap of 337.7M. Regarding current trading prices, AFMDQ is priced at $0.00, while SPHDF trades at $23.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas SPHDF's P/E ratio is -4.89. In terms of profitability, AFMDQ's ROE is -1.01%, compared to SPHDF's ROE of +6.85%. Regarding short-term risk, AFMDQ is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check SPHDF's competition here
AFMDQ vs NWBO Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, NWBO has a market cap of 326.2M. Regarding current trading prices, AFMDQ is priced at $0.00, while NWBO trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas NWBO's P/E ratio is -6.62. In terms of profitability, AFMDQ's ROE is -1.01%, compared to NWBO's ROE of +0.62%. Regarding short-term risk, AFMDQ is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check NWBO's competition here
AFMDQ vs CLVLY Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, CLVLY has a market cap of 315.4M. Regarding current trading prices, AFMDQ is priced at $0.00, while CLVLY trades at $6.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas CLVLY's P/E ratio is 13.90. In terms of profitability, AFMDQ's ROE is -1.01%, compared to CLVLY's ROE of +0.13%. Regarding short-term risk, AFMDQ is less volatile compared to CLVLY. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check CLVLY's competition here
AFMDQ vs NGENF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, NGENF has a market cap of 312.9M. Regarding current trading prices, AFMDQ is priced at $0.00, while NGENF trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas NGENF's P/E ratio is -15.19. In terms of profitability, AFMDQ's ROE is -1.01%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, AFMDQ is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check NGENF's competition here
AFMDQ vs CLVLF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, CLVLF has a market cap of 307.5M. Regarding current trading prices, AFMDQ is priced at $0.00, while CLVLF trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas CLVLF's P/E ratio is 13.56. In terms of profitability, AFMDQ's ROE is -1.01%, compared to CLVLF's ROE of +0.13%. Regarding short-term risk, AFMDQ and CLVLF have similar daily volatility (0.00).Check CLVLF's competition here
AFMDQ vs PBBIF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, AFMDQ is priced at $0.00, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, AFMDQ's ROE is -1.01%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, AFMDQ and PBBIF have similar daily volatility (0.00).Check PBBIF's competition here
AFMDQ vs ORYZF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, ORYZF has a market cap of 282.5M. Regarding current trading prices, AFMDQ is priced at $0.00, while ORYZF trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ORYZF's P/E ratio is -121.50. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ORYZF's ROE of -0.02%. Regarding short-term risk, AFMDQ is less volatile compared to ORYZF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check ORYZF's competition here
AFMDQ vs SCNLF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, SCNLF has a market cap of 254.3M. Regarding current trading prices, AFMDQ is priced at $0.00, while SCNLF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas SCNLF's P/E ratio is -24.50. In terms of profitability, AFMDQ's ROE is -1.01%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, AFMDQ is less volatile compared to SCNLF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check SCNLF's competition here
AFMDQ vs CMVLF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, CMVLF has a market cap of 251.9M. Regarding current trading prices, AFMDQ is priced at $0.00, while CMVLF trades at $3.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas CMVLF's P/E ratio is -5.18. In terms of profitability, AFMDQ's ROE is -1.01%, compared to CMVLF's ROE of -0.81%. Regarding short-term risk, AFMDQ and CMVLF have similar daily volatility (0.00).Check CMVLF's competition here
AFMDQ vs HNSBF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, AFMDQ is priced at $0.00, while HNSBF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas HNSBF's P/E ratio is -3.41. In terms of profitability, AFMDQ's ROE is -1.01%, compared to HNSBF's ROE of +2.02%. Regarding short-term risk, AFMDQ is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check HNSBF's competition here
AFMDQ vs SPHRF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, SPHRF has a market cap of 227.3M. Regarding current trading prices, AFMDQ is priced at $0.00, while SPHRF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas SPHRF's P/E ratio is -54.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, AFMDQ is less volatile compared to SPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check SPHRF's competition here
AFMDQ vs FGHQF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, FGHQF has a market cap of 223.1M. Regarding current trading prices, AFMDQ is priced at $0.00, while FGHQF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas FGHQF's P/E ratio is 11.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to FGHQF's ROE of +0.02%. Regarding short-term risk, AFMDQ is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check FGHQF's competition here
AFMDQ vs BOVNF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, AFMDQ is priced at $0.00, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas BOVNF's P/E ratio is -7.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to BOVNF's ROE of -0.54%. Regarding short-term risk, AFMDQ is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check BOVNF's competition here
AFMDQ vs FPHAF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, AFMDQ is priced at $0.00, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, AFMDQ's ROE is -1.01%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, AFMDQ and FPHAF have similar daily volatility (0.00).Check FPHAF's competition here
AFMDQ vs HLOSF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, HLOSF has a market cap of 193.8M. Regarding current trading prices, AFMDQ is priced at $0.00, while HLOSF trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas HLOSF's P/E ratio is -10.59. In terms of profitability, AFMDQ's ROE is -1.01%, compared to HLOSF's ROE of -0.75%. Regarding short-term risk, AFMDQ is less volatile compared to HLOSF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check HLOSF's competition here
AFMDQ vs SPHRY Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, SPHRY has a market cap of 193.6M. Regarding current trading prices, AFMDQ is priced at $0.00, while SPHRY trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas SPHRY's P/E ratio is -76.67. In terms of profitability, AFMDQ's ROE is -1.01%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, AFMDQ is less volatile compared to SPHRY. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check SPHRY's competition here
AFMDQ vs MLLCF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, MLLCF has a market cap of 181.9M. Regarding current trading prices, AFMDQ is priced at $0.00, while MLLCF trades at $4.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas MLLCF's P/E ratio is -2.49. In terms of profitability, AFMDQ's ROE is -1.01%, compared to MLLCF's ROE of -0.66%. Regarding short-term risk, AFMDQ is less volatile compared to MLLCF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check MLLCF's competition here
AFMDQ vs ADOCY Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, AFMDQ is priced at $0.00, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ADOCY's ROE of +8.60%. Regarding short-term risk, AFMDQ and ADOCY have similar daily volatility (0.00).Check ADOCY's competition here
AFMDQ vs PHCUF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, PHCUF has a market cap of 164.4M. Regarding current trading prices, AFMDQ is priced at $0.00, while PHCUF trades at $6.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas PHCUF's P/E ratio is 18.73. In terms of profitability, AFMDQ's ROE is -1.01%, compared to PHCUF's ROE of +0.17%. Regarding short-term risk, AFMDQ is less volatile compared to PHCUF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check PHCUF's competition here
AFMDQ vs IPHYF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, IPHYF has a market cap of 154.9M. Regarding current trading prices, AFMDQ is priced at $0.00, while IPHYF trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas IPHYF's P/E ratio is -2.62. In terms of profitability, AFMDQ's ROE is -1.01%, compared to IPHYF's ROE of +5.94%. Regarding short-term risk, AFMDQ is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check IPHYF's competition here
AFMDQ vs BBIXF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, BBIXF has a market cap of 151.8M. Regarding current trading prices, AFMDQ is priced at $0.00, while BBIXF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas BBIXF's P/E ratio is -13.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to BBIXF's ROE of -15.41%. Regarding short-term risk, AFMDQ is less volatile compared to BBIXF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check BBIXF's competition here
AFMDQ vs SLNCF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, SLNCF has a market cap of 150.2M. Regarding current trading prices, AFMDQ is priced at $0.00, while SLNCF trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas SLNCF's P/E ratio is -1.96. In terms of profitability, AFMDQ's ROE is -1.01%, compared to SLNCF's ROE of -1.22%. Regarding short-term risk, AFMDQ and SLNCF have similar daily volatility (0.00).Check SLNCF's competition here
AFMDQ vs AMGXF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, AMGXF has a market cap of 142.5M. Regarding current trading prices, AFMDQ is priced at $0.00, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, AFMDQ's ROE is -1.01%, compared to AMGXF's ROE of -0.71%. Regarding short-term risk, AFMDQ is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check AMGXF's competition here
AFMDQ vs KNTPF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, KNTPF has a market cap of 131.3M. Regarding current trading prices, AFMDQ is priced at $0.00, while KNTPF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas KNTPF's P/E ratio is -4.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to KNTPF's ROE of -0.63%. Regarding short-term risk, AFMDQ is less volatile compared to KNTPF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check KNTPF's competition here
AFMDQ vs HBPCF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, HBPCF has a market cap of 130.6M. Regarding current trading prices, AFMDQ is priced at $0.00, while HBPCF trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas HBPCF's P/E ratio is -42.75. In terms of profitability, AFMDQ's ROE is -1.01%, compared to HBPCF's ROE of -0.37%. Regarding short-term risk, AFMDQ and HBPCF have similar daily volatility (0.00).Check HBPCF's competition here
AFMDQ vs AAPGV Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, AFMDQ is priced at $0.00, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas AAPGV's P/E ratio is N/A. In terms of profitability, AFMDQ's ROE is -1.01%, compared to AAPGV's ROE of -2.50%. Regarding short-term risk, AFMDQ is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check AAPGV's competition here
AFMDQ vs TRGNF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, TRGNF has a market cap of 122.6M. Regarding current trading prices, AFMDQ is priced at $0.00, while TRGNF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas TRGNF's P/E ratio is -2.83. In terms of profitability, AFMDQ's ROE is -1.01%, compared to TRGNF's ROE of -0.64%. Regarding short-term risk, AFMDQ and TRGNF have similar daily volatility (0.00).Check TRGNF's competition here
AFMDQ vs PSTTF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, AFMDQ is priced at $0.00, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, AFMDQ's ROE is -1.01%, compared to PSTTF's ROE of N/A. Regarding short-term risk, AFMDQ and PSTTF have similar daily volatility (0.00).Check PSTTF's competition here
AFMDQ vs EPRXF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, AFMDQ is priced at $0.00, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, AFMDQ's ROE is -1.01%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, AFMDQ is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check EPRXF's competition here
AFMDQ vs BRIBF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, BRIBF has a market cap of 107.8M. Regarding current trading prices, AFMDQ is priced at $0.00, while BRIBF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas BRIBF's P/E ratio is -2.99. In terms of profitability, AFMDQ's ROE is -1.01%, compared to BRIBF's ROE of -0.09%. Regarding short-term risk, AFMDQ is less volatile compared to BRIBF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check BRIBF's competition here
AFMDQ vs ADOIF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, AFMDQ is priced at $0.00, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, AFMDQ and ADOIF have similar daily volatility (0.00).Check ADOIF's competition here
AFMDQ vs ORPOF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, ORPOF has a market cap of 100.3M. Regarding current trading prices, AFMDQ is priced at $0.00, while ORPOF trades at $4.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ORPOF's P/E ratio is -4.53. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ORPOF's ROE of N/A. Regarding short-term risk, AFMDQ and ORPOF have similar daily volatility (0.00).Check ORPOF's competition here
AFMDQ vs JWCTF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, JWCTF has a market cap of 98.9M. Regarding current trading prices, AFMDQ is priced at $0.00, while JWCTF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas JWCTF's P/E ratio is -1.19. In terms of profitability, AFMDQ's ROE is -1.01%, compared to JWCTF's ROE of -0.75%. Regarding short-term risk, AFMDQ is less volatile compared to JWCTF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check JWCTF's competition here
AFMDQ vs MSCLF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, MSCLF has a market cap of 96.6M. Regarding current trading prices, AFMDQ is priced at $0.00, while MSCLF trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas MSCLF's P/E ratio is 2.43. In terms of profitability, AFMDQ's ROE is -1.01%, compared to MSCLF's ROE of -0.61%. Regarding short-term risk, AFMDQ is less volatile compared to MSCLF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check MSCLF's competition here
AFMDQ vs NDTP Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, NDTP has a market cap of 89.8M. Regarding current trading prices, AFMDQ is priced at $0.00, while NDTP trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas NDTP's P/E ratio is -3.12. In terms of profitability, AFMDQ's ROE is -1.01%, compared to NDTP's ROE of -0.33%. Regarding short-term risk, AFMDQ is less volatile compared to NDTP. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check NDTP's competition here
AFMDQ vs MCURF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, AFMDQ is priced at $0.00, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas MCURF's P/E ratio is -16.90. In terms of profitability, AFMDQ's ROE is -1.01%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, AFMDQ is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check MCURF's competition here
AFMDQ vs POLBF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, POLBF has a market cap of 81.4M. Regarding current trading prices, AFMDQ is priced at $0.00, while POLBF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas POLBF's P/E ratio is -11.54. In terms of profitability, AFMDQ's ROE is -1.01%, compared to POLBF's ROE of -0.55%. Regarding short-term risk, AFMDQ is less volatile compared to POLBF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check POLBF's competition here
AFMDQ vs RECEF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, RECEF has a market cap of 80.4M. Regarding current trading prices, AFMDQ is priced at $0.00, while RECEF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas RECEF's P/E ratio is -3.67. In terms of profitability, AFMDQ's ROE is -1.01%, compared to RECEF's ROE of +2.79%. Regarding short-term risk, AFMDQ is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for AFMDQ.Check RECEF's competition here
AFMDQ vs ETXPF Comparison June 2026
AFMDQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFMDQ stands at 1.6K. In comparison, ETXPF has a market cap of 76M. Regarding current trading prices, AFMDQ is priced at $0.00, while ETXPF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFMDQ currently has a P/E ratio of N/A, whereas ETXPF's P/E ratio is -6.50. In terms of profitability, AFMDQ's ROE is -1.01%, compared to ETXPF's ROE of -0.51%. Regarding short-term risk, AFMDQ and ETXPF have similar daily volatility (0.00).Check ETXPF's competition here